Citation Impact
Citing Papers
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
2021
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
“Selective” serotonin 5-HT2A receptor antagonists
2022
Psychedelic-inspired drug discovery using an engineered biosensor
2021
Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs
2018
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Psychedelics
2016 Standout
Clinical applications of hallucinogens: A review.
2016
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
2018
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
The neural basis of psychedelic action
2022 Standout
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
2020
Psychedelics
2022
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
2015
Pharmacological characterization of the seven human NOX isoforms and their inhibitors
2019
The promises and perils of psychedelic pharmacology for psychiatry
2022
Psychedelics and Other Psychoplastogens for Treating Mental Illness
2021
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)
2019
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
2020
Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor
2020
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
2021
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
2020
Works of Jason Wallach being referenced
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)
2015
Endogenous hallucinogens as ligands of the trace amine receptors: A possible role in sensory perception
2008
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)
2018
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
2020
Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
2017
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)
2017
From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs
2014
Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)
2017
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ)
2016